Cintia Gisela Cevallos

Biography:

My name is Cintia Cevallos from Argentina and I will proceed to describe briefly my academic and professional training.
2010: I started an internship as an undergraduate student to obtain a bachelor's degree at the School of Chemistry, Biochemistry and Pharmacy, University of San Luis, Argentina. Research topic: Effects of exposure to cadmium in drinking water on parameters related to oxidative stress in the small intestine of rats. Supervisor: Dr. Larregle Ethel Viviana.
2012: I got a BSc. in Molecular Biology from the School of Chemistry, Biochemistry and Pharmacy, University of San Luis, Argentina.
2013: I started my doctoral studies when the National Research Council from Argentina (CONICET) awarded me with a fellowship. Research project: Study of the evolution of the Human Immunodeficiency Virus (HIV) in Men who have sex with men in Argentina (2000-2013) at the Institute for Biomedical Research on Retroviruses and AIDS (INBIRS, School of Medicine, University of Buenos Aires). Supervisor: Dr. Maria Mercedes Avila and co-supervisor: Dr. Jorge Quarleri.
2019: I got a PhD. in Medical Science from the School of Medical Sciences, University of Buenos Aires, Argentina. In this year I also worked as a Forensic expert for the Scientific Police Department of Buenos Aires city in the forensic genetics area.
2020: I started my post-doctoral studies when the National Research Council from Argentina (CONICET) awarded me with a fellowship. Research project: Cellular cross-talk and modulation of the hepatic profibrotic profile in the context of HIV-HCV coinfection. Supervisor: Dr. Jorge Quarleri.
Furthermore, since the COVID-19 outbreak, I also started to participate in the diagnosis area of INBIRS Institute processing a large number of samples (nasopharyngeal swabs) for SARS-CoV-2 detection, working under ISO9001 requirements.
2021: In the context of the SARS-CoV-2 pandemic as a postdoctoral student I joined to work on a research project focused on evaluating the direct mechanisms of pathogenesis cells associated with the coronavirus SARS-CoV-2.